🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Maersk Line plans pharma transport market push with new digital tool

Published 26/06/2017, 10:43
© Reuters.  Maersk Line plans pharma transport market push with new digital tool
MAERSKb
-

COPENHAGEN (Reuters) - Maersk Line, the world's largest container shipping firm, is looking to expand in the air freight-dominated pharmaceuticals transport market, as it has completed fitting its refrigerated containers with a digital tool that helps monitor temperature.

The company, a part of A.P. Moller-Maersk (CO:MAERSKb), said it had finished installing the Remote Container Management (RCM) tool on all of its 270,000 refrigerated containers, also known as reefers, and will now offer it to customers.

The tool will help measure location, temperature, humidity and power status in real time.

With the tool, Maersk is hoping to grow volumes within more traditional chilled perishable cargo like bananas, fish and meat, but also to expand into transport of high-valued pharmaceutical products where it now has a small presence.

Pharmaceuticals are currently transported mainly via air and less than 20 percent is being shipped, Maersk's head of Reefer, Anne Sophie Zerlang told Reuters on Monday, adding that the market had a potential to reach 100,000 containers a year.

"We're definitely looking to make the container market bigger by RCM," Zerlang said. "We are also hoping to penetrate newer markets like the pharma industry ... It has a very big potential but has extremely specific requirements because of the very high value of the cargo."

Maersk expects to transport one million reefers this year.

The RCM tool is the latest in the more than 100-year old conglomerate A.P. Moller-Maersk's push into new technologies.

The container shipping industry has lagged some other sectors in bringing more of its processes online, and there is still a huge amount of paperwork slowing down the handling and tracking of containers.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.